Rein Therapeutics to Present at Upcoming September Investor Conferences
Rein Therapeutics will webcast two New York investor conference presentations in mid-September 2026 for online and replay viewing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Rein Therapeutics (RNTX) will present at two investor conferences in September 2026. President and CEO Brian Windsor is scheduled to speak at the 2026 Cantor Global Healthcare Conference on September 11, 2026, at 8:00 a.m. ET in New York, NY, and at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, at 11:00 a.m. ET, also in New York.
A live webcast of both presentations will be available through the Investors section of the company’s website, with archived replays accessible for approximately 90 days after the events.
Details
News Market Reaction – RNTX
On Sep 4, the first trading day after this news, RNTX closed 5.39% above the previous close. Argus tracked a peak move of +5.8% during that session. Argus tracked a trough of -3.3% from its starting point during tracking. Our momentum scanner recorded 7 alerts for this stock that day. Relative volume reached 37.8x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 4 session.
Key Figures
- Cantor conference date
- September 11, 2026
- 2026 Cantor Global Healthcare Conference
- Cantor presentation time
- 8:00 a.m. ET
- September 11, 2026
- Wainwright conference date
- September 14, 2026
- H.C. Wainwright 28th Annual Global Investment Conference
- Wainwright presentation time
- 11:00 a.m. ET
- September 14, 2026
- Replay availability
- approximately 90 days
- Following the conferences
Historical Context
-
FDA Fast Track designation for LTI-03 in idiopathic pulmonary fibrosis
-
Second-quarter results included financing, trial progress, and operating expense updates
-
Peer-reviewed first-in-human LTI-03 data were published in Nature Communications
-
RENEW Phase 2 trial began enrollment across all five planned countries
-
First patient randomized in United Kingdom, expanding RENEW trial enrollment footprint
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
AUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that Brian Windsor, President and Chief Executive Officer of Rein Therapeutics, will present at the following investor conferences in September.
2026 Cantor Global Healthcare Conference
Date & Time: Friday, September 11, 2026, at 8:00 a.m. ET
Location: New York, NY
H.C. Wainwright 28th Annual Global Investment Conference
Date: Monday, September 14, 2026 at 11:00 a.m. ET
Location: New York, NY
A live webcast of the presentations may be accessed via the Investors section of the Rein website at ir.reintx.com. An archived replay of the events will be available on the website for approximately 90 days following the conference.
About Rein Therapeutics
Rein Therapeutics is a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class therapies to address significant unmet medical needs in orphan pulmonary and fibrosis indications. Rein’s lead product candidate, LTI-03, is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 has received both Orphan Drug and Fast Track designations in the U.S.
Investor Contact
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Rein Therapeutics (RNTX) present at the 2026 Cantor Global Healthcare Conference?
Rein Therapeutics is scheduled to present at the 2026 Cantor Global Healthcare Conference on Friday, September 11, 2026, at 8:00 a.m. ET in New York, NY. The presentation will also be available via live webcast on the company’s investor website.
What is the date and time of Rein Therapeutics (RNTX) presentation at the H.C. Wainwright 28th Annual Global Investment Conference?
Rein Therapeutics plans to present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, at 11:00 a.m. ET in New York, NY, with the session accessible through a live webcast on its investor site.
Who will present for Rein Therapeutics (RNTX) at the September 2026 investor conferences?
Brian Windsor, President and Chief Executive Officer of Rein Therapeutics, will present at both the 2026 Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference in New York.
How can investors access the Rein Therapeutics (RNTX) webcasts for the September 2026 conferences?
Investors can access live webcasts of Rein Therapeutics’ September 2026 conference presentations via the Investors section of the company’s website at ir.reintx.com. An archived replay of the events will be available on the site for approximately 90 days.
Will replays of the Rein Therapeutics (RNTX) September 2026 investor presentations be available?
Yes. An archived replay of Rein Therapeutics’ investor conference presentations will be available on the company’s investor website for approximately 90 days following the conferences.